Hematopoietic Stem Cell Transplantation (HCT)
Showing 1 - 25 of >10,000
Cancer Trial in Boston (CARE, Standard Transplant Care)
Active, not recruiting
- Cancer
- CARE
- Standard Transplant Care
-
Boston, MassachusettsMassachusetts General Hospital
Jan 24, 2023
Stem Cell Transplant Trial in Scottsdale (Digital stories, Informational videos)
Completed
- Stem Cell Transplant
- Digital stories
- Informational videos
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jul 18, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +3 more
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
-
Columbus, Ohio
- +1 more
Apr 20, 2022
Psychological Intervention for Caregivers of Patients Undergoing
Completed
- Stem Cell Transplant Complications
- Qualitative Interviews
-
Boston, MassachusettsMassachusetts general Hospital
Aug 31, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Bone Marrow Transplant Complications, Hematologic Malignancy Trial in Boston (CARE Application, Usual Care)
Not yet recruiting
- Bone Marrow Transplant Complications
- Hematologic Malignancy
- CARE Application
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 1, 2023
Hematopoietic Steam Cell Transplantation (HCT) Trial in Raleigh (Acceptance and Commitment Therapy (ACT))
Recruiting
- Hematopoietic Steam Cell Transplantation (HCT)
- Acceptance and Commitment Therapy (ACT)
-
Raleigh, North CarolinaLauren Hill
Mar 29, 2022
Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)
Not yet recruiting
- Hematologic Cancer
- Hematologic Malignancy
- CBT for Fatigue
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 3, 2023
Sickle Cell Disease Trial in Duarte (drug, procedure, radiation)
Recruiting
- Sickle Cell Disease
- Alemtuzumab
- +3 more
-
Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
Jul 31, 2022
Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))
Recruiting
- Hematologic Malignancy
- CD45RA depleted donor lymphocyte infusion (DLI)
-
Tuebingen,, Germany
- +1 more
Jul 13, 2023
Hematopoietic Stem Cell Transplantation, Art Therapy, Physical Therapy Trial (Art and Physical Therapy, Physical Therapy)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- +2 more
- Art and Physical Therapy
- Physical Therapy
- (no location specified)
Aug 11, 2022
Hematopoietic Stem Cell Transplantation Trial in Ann Arbor (Bob's Red MillĀ®, Starch Placebo)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Bob's Red MillĀ®
- Starch Placebo
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Dec 20, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Diseases, Sexual Dysfunction Trial in Boston (Enhanced Standard Care,
Recruiting
- Hematopoietic Stem Cell Transplantation
- +2 more
- Enhanced Standard Care
- Multimodal Intervention to Address Sexual Dysfunction
-
Boston, MassachusettsMassachusetts General Hospital
Aug 23, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Biospecimen Collection
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 9, 2023
Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation
Not yet recruiting
- Acute Leukemia
- +4 more
- Haploidentical hematopoietic cell transplantation (haploHCT)
- matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
- (no location specified)
Jul 13, 2022
Acute Leukemia, Myelodysplastic Syndrome Trial in Duarte (Hematopoietic Cell Transplantation, Intensity-Modulated Radiation
Recruiting
- Acute Leukemia
- Myelodysplastic Syndrome
- Hematopoietic Cell Transplantation
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancies
- Busulfan 3.2 mg/kg/day
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 14, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022
Adult Lymphoblastic Lymphoma Trial in Birmingham (Fludarabine, Total Body Irradiation)
Completed
- Adult Lymphoblastic Lymphoma
- Fludarabine
- Total Body Irradiation
-
Birmingham, AlabamaUAB Bone Marrow Transplantation and Cellular Therapy Program
Aug 23, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022